OTCMKTS:PBSV Pharma-Bio Serv (PBSV) Stock Price, News & Analysis $0.35 -0.09 (-20.45%) As of 03:41 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsNews and TrendsSEC Filings About Pharma-Bio Serv Stock (OTCMKTS:PBSV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Pharma-Bio Serv alerts:Sign Up Key Stats Today's Range$0.32▼$0.3650-Day Range$0.35▼$0.5852-Week Range$0.32▼$1.36Volume22,620 shsAverage Volume2,424 shsMarket Capitalization$8.02 millionP/E Ratio35.04Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Pharma-Bio Serv, Inc. is a professional services and consulting company that supports organizations operating in highly regulated life-sciences industries. Its clients include pharmaceutical, biotechnology, medical device, nutraceutical and related healthcare companies. The company provides services intended to help clients develop, implement and maintain compliant operations. Its areas of expertise include regulatory compliance, quality systems, validation, quality assurance, manufacturing support, engineering and project management. Pharma-Bio Serv also assists with regulatory and technical matters associated with facilities, processes, equipment and products. Pharma-Bio Serv is based in Puerto Rico and has historically served customers in Puerto Rico, the United States and other international markets. The company was established to provide specialized technical and compliance support to regulated industries, although detailed information about its current leadership and geographic operating structure is limited.AI Generated. May Contain Errors. Read More Receive PBSV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PBSV Stock News HeadlinesPharma-Bio Serv (PBSV)September 25 at 6:29 PM | mx.investing.comPharma-Bio Serv (OTCMKTS:PBSV) Shares Cross Below Two Hundred Day Moving Average - Here's What HappenedSeptember 24, 2026 | americanbankingnews.comBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing December 8th.September 28 at 1:00 AM | Paradigm Press (Ad)Zacks Research Forecasts Lower Earnings for Pharma-Bio ServSeptember 18, 2026 | americanbankingnews.comPBSV Changes Proving to be Beneficial to BusinessSeptember 15, 2026 | msn.comPBSV is a Small Stock Worth a LookJune 16, 2026 | finance.yahoo.comPharma-Bio Serv Inc.: Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026June 15, 2026 | finanznachrichten.dePBSV Showing Improved Operations and Strong DividendMarch 18, 2026 | finance.yahoo.comSee More Headlines PBSV Stock Analysis - Frequently Asked Questions How have PBSV shares performed this year? Pharma-Bio Serv's stock was trading at $0.60 at the start of the year. Since then, PBSV shares have decreased by 41.7% and is now trading at $0.35. How were Pharma-Bio Serv's earnings last quarter? Pharma-Bio Serv Inc. (OTCMKTS:PBSV) issued its quarterly earnings data on Monday, June, 15th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.03 by $0.02. The firm earned $2.70 billion during the quarter, compared to the consensus estimate of $2.70 million. Pharma-Bio Serv had a net margin of 2.66% and a trailing twelve-month return on equity of 2.34%. How do I buy shares of Pharma-Bio Serv? Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pharma-Bio Serv own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pharma-Bio Serv investors own include AT&T (T), Annaly Capital Management (NLY), BlackRock Multi-Sector Income Trust (BIT), GE Aerospace (GE), ExxonMobil (XOM), Enterprise Products Partners (EPD) and First BanCorp. (FBP). Company Calendar Last Earnings6/15/2026Today9/28/2026Fiscal Year End10/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorIndustrials Industry Consulting Sub-IndustryBusiness Services Current SymbolOTCMKTS:PBSV CIK1304161 Webwww.pharmabioserv.com Phone(787) 278-2709Fax787-796-5168Employees185Year Founded1993Profitability EPS (Trailing Twelve Months)$0.01 Trailing P/E Ratio35.04 Forward P/E Ratio8.75 P/E GrowthN/ANet Income-$100 thousand Net Margins2.66% Pretax Margin2.83% Return on Equity2.34% Return on Assets2.01% Debt Debt-to-Equity RatioN/A Current Ratio11.30 Quick Ratio11.30 Sales & Book Value Annual Sales$9 million Price / Sales0.89 Cash FlowN/A Price / Cash FlowN/A Book Value$0.52 per share Price / Book0.67Miscellaneous Outstanding Shares22,900,000Free Float20,016,000Market Cap$8.02 million OptionableNot Optionable Beta0.71 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (OTCMKTS:PBSV) was last updated on 9/28/2026 by MarketBeat.com Staff. From Our PartnersManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredElon Musk’s Hushed FCC Filing. Dec 8th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma-Bio Serv Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharma-Bio Serv With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
